Search clinical trials for: 68Ga-NY104

Total 559 results

St Vincent's Hospital, Sydney
Novartis

Recruiting

Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer

Breast Cancer

Australia
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer

Bladder Cancer

United States
Fujian Medical University

Not yet recruiting

Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer

Gastric Cancer | Peritoneal Carcinomatosis | 68Ga-FAPI PET/CT | Enhanced CT | 18F-FDG PET/CT

China
Peking Union Medical College Hospital

Recruiting

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Lung Cancer | Neuroendocrine Neoplasm

China
Turku University Hospital

Active, not recruiting

Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis (SIGLEC)

Rheumatoid Arthritis | Vasculitis | Healthy Subjects | Pulmonary Sarcoidosis

Finland
Vanderbilt-Ingram Cancer Center

Completed

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer (68Ga)

Neuroendocrine Carcinoma

United States
Huashan Hospital

Recruiting

Clinical Study of TROP-2 PET/CT for Noninvasive Diagnosis of Solid Tumors

Neoplasms | Positron-Emission Tomography

China
Centre de recherche du Centre hospitalier universitaire...

Recruiting

68Ga-PSMA-617 PET/CT for PSMA-expressing Tumor: a Pragmatic Study

Solid Cancers

Canada
University Hospital, Brest

Recruiting

Ventilation/Perfusion PET/CT With Galligas and 68Ga-MAA for Regional Lung Function Assessment After Pulmonary Embolism (EOLE)

Pulmonary Embolism | Dyspnea

France
British Columbia Cancer Agency

Active, not recruiting

68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical

Neoplasms | Urogenital Neoplasms | Disease Attributes | Prostate Cancer | Prostatic Neoplasm | Prostatic Disease

Canada
Clinuvel Pharmaceuticals Limited

Completed

A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)

Erythropoietic Protoporphyria
The First Affiliated Hospital of Xiamen University

Unknown

18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

Lung Adenocarcinoma | PET/CT | 18F-FDG | 68Ga-FAPI

China
Rigshospitalet, Denmark

Unknown

RGD PET/MRI in Sporadic Vestibular Schwannoma

Acoustic Neuroma

Denmark
Maastricht University Medical Center

Not yet recruiting

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.

Breast Cancer | Breast Neoplasms | Breast Diseases

Netherlands
Weill Medical College of Cornell University

Recruiting

Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC

Prostate Cancer

United States
Peking Union Medical College Hospital

Completed

68Ga-P16-093 and 18F-FDG PET/CT Imaging in the Same Group of Clear Cell Renal Cell Carcinoma Patients

Clear Cell Renal Cell Carcinoma

China
Emory University
National Cancer Institute (NCI); National Institutes of Health (NIH); Telix Pharmaceuticals...

Active, not recruiting

Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes

Prostate Adenocarcinoma

United States
University Hospital, Bordeaux

Completed

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks (UROPET)

Prostate Cancer

France
Central Hospital, Nancy, France

Not yet recruiting

Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis (HEFITEP)

Non-alcoholic Steatohepatitis
Huashan Hospital

Recruiting

A Study of the Clinical Application of [18F]RCCB6 and [68Ga]Ga-NOTA-RCCB6 PET/CT Imaging in the Diagnosis of CD70-expressing Multiple Tumors

Kidney Cancer | Positron Emission Tomography | Lymphomas

China
Karolinska University Hospital
Uppsala University; Stockholm South General Hospital

Recruiting

68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study

Cancer

Sweden
Medical University Innsbruck
European Union

Completed

MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT

Gastrointestinal Stromal Tumors

Austria
Novartis Pharmaceuticals

Recruiting

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Glioblastoma Multiforme | Gastroesophageal Adenocarcinoma | Pancreatic Ductal Adenocarcinoma

Netherlands, Spain, Israel, United States, Switzerland
Radio Isotope Therapy of America
Excel Diagnostics and Nuclear Oncology Center; Radiomedix, Inc.

Completed

68-Ga-DOTATATE PET-CT Scan for Diagnosis of Primary and Metastatic Somatostatin Receptor-positive Neuroendocrine Tumors (NETs)

Neuroendocrine Carcinoma

United States
Peking Union Medical College Hospital
Stanford University

Unknown

68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

China
ABSCINT NV/SA

Not yet recruiting

HER2 Targeted Molecular Imaging in mBC Using 68Ga-ABS011 (HERMIA)

Metastatic Breast Cancer

Belgium
Shanghai General Hospital, Shanghai Jiao Tong University...
NanoMab Technology (UK) Limited

Completed

99mTc/68Ga Labeled Anti-PD-L1 sdAb in Assessment of PD-L1 Expression in NSCLC

Non-Small Cell Lung Cancer

China
Weill Medical College of Cornell University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Evaluation of PSMA Antagonist Produced by Two Different Methods

Metastatic Prostate Adenocarcinoma

United States
Peking Union Medical College Hospital

Recruiting

Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients

Prostate Cancer

China
Andrei Iagaru

Completed

68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Prostate Adenocarcinoma

United States
Cytosite Biopharma Inc.
Massachusetts General Hospital; University of Alabama at Birmingham; Chang Gung...

Recruiting

Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors

Lymphoma | Solid Tumor, Unspecified, Adult

United States, Taiwan
Rigshospitalet, Denmark

Unknown

uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer

Neoplasms | Neoplasms by Site | Head and Neck Neoplasms | Oral Cancer | Oropharyngeal Cancer | Cancer of Mouth

Denmark
New York Institute of Technology
Michael J. Fox Foundation for Parkinson's Research

Completed

The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease

Parkinson's Disease

United States
Rigshospitalet, Denmark

Completed

PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

Neuroendocrine Tumors

Denmark
Turku University Hospital

Completed

Molecular and Whole-body MR Imaging in Lymphomas (MILY)

Lymphoma | Lymphoma, Non-Hodgkin | Hodgkin Disease

Finland
The First Affiliated Hospital of Xiamen University

Recruiting

ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer

Solid Tumor | Thyroid Cancer | Tumor | Positron-Emission Tomography

China
Chang Gung Memorial Hospital

Recruiting

Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer

Ovarian Cancer

Taiwan
Andrei Iagaru
General Electric

Completed

68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Not yet recruiting

Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

Hyperaldosteronism | Hypercortisolism | Cushing s Syndrome

United States
Assistance Publique - Hôpitaux de Paris

Terminated

68Ga-DOTATATE PET-CTA Imaging for the Early Detection of Progressing Coronary Atherosclerosis (iPROGRESS)

Coronary Arteriosclerosis

France
Memorial Sloan Kettering Cancer Center

Completed

68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

Prostate Cancer

United States
National University Hospital, Singapore

Unknown

Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts

Tuberculosis, Pulmonary

Singapore
Weill Medical College of Cornell University
POINT Biopharma

Suspended

Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
University of California, Davis
National Institutes of Health (NIH)

Recruiting

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

Metastatic Cancer

United States
Peking Union Medical College Hospital

Active, not recruiting

[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients

Insulinoma

China
University of Edinburgh

Recruiting

Fibrosis in Chronic and Delayed Myocardial Infarction (FCDMI)

Aortic Stenosis | Carcinoid Syndrome | Chemotherapy Induced Systolic Dysfunction

United Kingdom
Peking Union Medical College Hospital

Recruiting

Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy With 177Lu-EB-FAPI

177Lu-EB-FAPI

China
Irene Burger

Completed

Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA

Prostate Cancer

Switzerland
University of California, Davis
United States Department of Defense

Recruiting

Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6

Metastatic Nonsmall Cell Lung Cancer

United States
University of Edinburgh

Recruiting

Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition (CHIEFTain)

Myocarditis | Hypertrophic Cardiomyopathy | Cardiac Sarcoidosis | Heart Failure With Preserved Ejection Fraction | Hypertensive Heart Disease | Arrhythmogenic Right Ventricular Cardiomyopathy 1 | Tako Tsubo Cardiomyopathy

United Kingdom

Search clinical trials for: 68Ga-NY104

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations